This topic contains a solution. Click here to go to the answer

Author Question: A document that provides a general statement about a research study and the right to withdraw ... (Read 110 times)

roselinechinyere27m

  • Hero Member
  • *****
  • Posts: 557
A document that provides a general statement about a research study and the right to withdraw participation without penalty is called a(n)
 
  a) informed consent
 b) debriefing statement.
 c) institutional review board application.
 d) literature review.

Question 2

As a young professor, Dr. X wants to test consumer preference for shoe style and color. He has five pairs of shoes, each in two different colors. Although he has some resources, they are not unlimited.
 
  Therefore, he would choose which research design?
   a) Incomplete counterbalancin
 b) Complete counterbalancing
 c) Within-subject counterbalancing
 d) Balancing



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

otokexnaru

  • Sr. Member
  • ****
  • Posts: 314
Answer to Question 1

A

Answer to Question 2

A





 

Did you know?

Cyanide works by making the human body unable to use oxygen.

Did you know?

Your heart beats over 36 million times a year.

Did you know?

Looking at the sun may not only cause headache and distort your vision temporarily, but it can also cause permanent eye damage. Any exposure to sunlight adds to the cumulative effects of ultraviolet (UV) radiation on your eyes. UV exposure has been linked to eye disorders such as macular degeneration, solar retinitis, and corneal dystrophies.

Did you know?

Pink eye is a term that refers to conjunctivitis, which is inflammation of the thin, clear membrane (conjunctiva) over the white part of the eye (sclera). It may be triggered by a virus, bacteria, or foreign body in the eye. Antibiotic eye drops alleviate bacterial conjunctivitis, and antihistamine allergy pills or eye drops help control allergic conjunctivitis symptoms.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library